Advanced Accelerator Application SA (ADR) (NASDAQ:AAAP) has announced the expansion of its theranostic pipeline with the addition of NeoBOMB1, which it describes as a novel GRPR antagonist. The ...
Results that may be inaccessible to you are currently showing.
Hide inaccessible results